A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro

Molecular Pharmacology

Volumn 54, Issue 5, 1998, Pages 874-880

  Gridley, Kelly E ^a   Green, Pattie S ^a   Simpkins, James W ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; GLUTATHIONE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; DEGENERATIVE DISEASE; DRUG EFFECT; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031724393     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.5.874     Document Type: Article

References (40)

1. Behl C, Davis J, Cole GM, and Schubert D (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun 186:944-950.
2. Behl C, Davis JB, Lesley R, and Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
3. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, and Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535-541.
4. Behl C, Widmann M, Trapp T, and Holsboer F (1995) 17 β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482.
5. Black L and Berenbaum MC (1964) Factors affecting the dye exclusion test for cell viability. Exp Cell Res 35:9-13.
6. Capel ID, Jenner M, Williams DC, Donaldson D, and Nath A (1981) The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. J Steroid Biochem 14:729-732.
7. Chandler LJ, Sumners C, and Crews FT (1993) Ethanol inhibits NMDA receptor-mediated excitotoxicity in rat primary neuronal cultures. Alcohol Clin Exp Res 17:54-60.
8. Elce JS and Harris J (1971) Conjugation of 2-Hydroxyestradiol-17β (1, 3, 5(10)-estratriene-2,3,17β-triol) with glutathione in the rat. Steroids 18:583-591.
9. Good PF, Werner P, Hsu A, Olanow CW, and Perl DP (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 149:21-28.
10. Goodman Y, Bruce AJ, Cheng B, and Mattson MP (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844.
11. Green PS, Bishop J, and Simpkins JW (1997a) 17 α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511-515.
12. Green PS, Gordon K, and Simpkins JW (1997b) Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
13. Green PS, Gridley KE, and Simpkins JW (1996) Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165-168.
14. Green PS, Gridley KE, and Simpkins JW (1998) Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione. Neuroscience 84:7-10.
15. Gridley KE, Green PS, and Simpkins JW (1997) Low concentrations of estradiol reduce β-amyloid (25-35) induced toxicity, lipid peroxidation, and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778:158-165.
16. Halliwell B and Gutteridge JMC (1989) Free Radicals in Biology and Medicine. Oxford University Press, New York.
17. Jaiswal AK (1994) Antioxidant response element. Biochem Pharm 48:439-444.
18. Jellnick PH and Bradlow HL (1990) Peroxidase-catalyzed displacement of tritium from regiospecifically labeled estradiol and 2-hydroxyestradiol. J Steroid Biochem 35:705-710.
19. Jellnick PH, Lewis J, and Boston F (1967) Further evidence for the formation of an estrogen-peptide conjugate by rat liver in vitro. Steroids 10:329-346.
20. Keller J, Germeyer A, Begley J, and Mattson M (1997) 17 β-estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide. J Neurosci Res 50:522-530.
21. Lacort M, Leal AM, Liza M, Martin C, Martinez R, and Ruiz-Larrea B (1995) Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 30:141-146.
22. Massafra C, Buoonocore G, Berni S, Gioia D, Giulani A, and Vezzosi P (1993) Antioxidant erythrocyte enzyme activities during oral contraception. Contraception 47:591-596.
23. Mattson M, Robinson N, and Guo Q (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8:3817-3821.
24. Mattson MP, Tomaselli KJ, and Rydel RE (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49.
25. Meister A and Anderson ME (1983) Glutathione. Annu Rev Biochem 52:711-760.
26. Miller CP, Jirkovsky I, Hayhurst DA, and Adelman SJ (1996) In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61:305-308.
27. Montano MM and Katzenellenbogen BS (1997) The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94:2581-2586.
28. Mooradian AD (1993) Antioxidant properties of steroids. J Steroid Biochem Mol Biol 45:509-511.
29. Mukai K, Daifuku K, Yokoyama S, and Nakano M (1990) Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1035:348-352.
30. Paganini-Hill A and Henderson VW (1994) Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140:256-261.
31. Pike CJ, Walencewicz AJ, Glabe CG, and Cotman CW (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563: 311-314.
32. Ruiz-Larrea B, Leal A, Martin C, Martinez R, and Lacort M (1995) Effects of estrogens on the redox chemistry of iron: A possible mechanism of the antioxidant action of estrogens. Steroids 60:780-783.
33. Sagara Y, Dargusch R, Klier FG, Schubert D, and Behl C (1996) Increased antioxidant enzyme activity in amyloid β protein-resistant cells. J Neurosci 16:497-505.
34. Selkoe DJ (1997) Alzheimer's disease: genotypes, phenotype, and treatments. Science (Washington DC) 275:630-631.
35. Smith CV, Jones DP, Guenthner TM, Lash LH, and Lauterburg BH (1996) Compartmentation of glutathione: implications for the study of toxicity and disease. Toxicol Appl Pharmacol 140:1-12.
36. Sugioka K, Shimosegawa Y, and Nakano M (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett 210:37-39.
37. Tang M, Abplanalp W, Ayres S, and Subbiah MTR (1996a) Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 45:411-414.
38. Tang M-X, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, and Mayeux R (1996b) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
39. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, and Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature (Lond) 382:685-691.
40. Yankner BA, Dawes LR, Fisher S, Villa-Koaroff L, Oster-Granite ML, and Neve RL (1989) Neurotoxicity of fragment of the amyloid precursor associated with Alzheimer's disease. Science (Washington DC) 245:417-520.